The Clinical Study Report (CSR) is a comprehensive document that describes the methods, results, and conclusions of a clinical trial in accordance with ICH E3 guidelines. The CSR serves as the primary documentation of trial conduct and findings for regulatory submission and scientific publication.
What Is a Clinical Study Report?
A CSR integrates data from all phases of a clinical trial into a single authoritative document, providing a detailed description of the study design, statistical methods, subject demographics, efficacy results, and safety data. The report must be prepared after trial completion and database lock, and it is typically signed by the sponsor’s responsible medical officer and the coordinating investigator. The CSR is the basis for regulatory review and the common technical document (CTD) submission for marketing authorization.
Regulatory Framework
ICH E3 provides the structure and content requirements for CSRs, which are accepted by regulatory authorities in the United States, Europe, Japan, and other ICH regions. The FDA and EMA require that CSRs be submitted as part of a New Drug Application (NDA) or Marketing Authorization Application (MAA) . Additional guidance on CSR format and electronic submission is provided by the ICH M4 CTD guidelines.
Key Requirements
The CSR must include an ethics committee and informed consent section, a detailed description of the study population, a full accounting of all subjects who discontinued or were withdrawn, and comprehensive adverse event tabulations. The statistical analysis must be pre-specified in the Statistical Analysis Plan (SAP) and any deviations from the plan must be justified. Interim analyses must be clearly identified if included.
Documentation
The CSR is supported by the Trial Master File (TMF) , which contains the protocol, case report forms, monitoring reports, and all source documents. Appendices to the CSR typically include the protocol and amendments, sample case report forms, investigator listings, and the SAP. The CSR and its supporting documents must be archived for the period required by applicable regulations.
Conclusion
The Clinical Study Report is the definitive record of a clinical trial’s conduct and outcomes. Preparation in accordance with ICH E3 ensures that the report meets regulatory expectations and supports the marketing authorization process. A well-prepared CSR reflects the quality and integrity of the underlying clinical research.
